Surviving Testicular Cancer: The Role of the Contralateral Testicle

Affiliations

¹ Keck School of Medicine, University of Southern California, Los Angeles, CA.
² Division of Hematology, Oncology Department of Medicine, University of Rochester School of Medicine and Dentistry, James P. Wilmot Cancer Institute, Rochester, NY.

Editorial

Anishka D'souza et al. J Clin Oncol. 2021.

. 2021 Feb 1;39(4):265-268.

doi: 10.1200/JCO.20.03333.

¹ Keck School of Medicine, University of Southern California, Los Angeles, CA.
² Division of Hematology, Oncology Department of Medicine, University of Rochester School of Medicine and Dentistry, James P. Wilmot Cancer Institute, Rochester, NY.

No abstract available

Comment on

Dose-Dependent Effect of Platinum-Based Chemotherapy on the Risk of Metachronous Contralateral Testicular Cancer.
Blok JM, Groot HJ, Huele EH, de Wit R, Horenblas S, Nuver J, Groenewegen G, Bosch JLHR, Witjes JA, Tromp JM, de Brouwer PJM, van den Berg HA, Vanneste BGL, Smilde TJ, Aarts MJB, Gietema JA, Meijer RP, Schaapveld M. Blok JM, et al. J Clin Oncol. 2021 Feb 1;39(4):319-327. doi: 10.1200/JCO.20.02352. Epub 2020 Oct 29. J Clin Oncol. 2021. PMID: 33119475
Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study.
Hellesnes R, Myklebust TÅ, Bremnes RM, Karlsdottir Á, Kvammen Ø, Negaard HFS, Tandstad T, Wilsgaard T, Fosså SD, Haugnes HS. Hellesnes R, et al. J Clin Oncol. 2021 Feb 1;39(4):308-318. doi: 10.1200/JCO.20.02713. Epub 2020 Dec 23. J Clin Oncol. 2021. PMID: 33356420